Download | < Back |
20 Sep 2017 | |
Sub: Glenmark Pharmaceuticals receives ANDA approval for Nitroglycerin Sublingual Tablets USP, 0.3 mg, 0.4 mg, and 0.6 mg<BR> <BR> With reference to the subject mentioned above, kindly find attached media release which is self-explanatory. <BR> <BR> Request you to kindly take the same on record.<BR> <BR> | |
View all announcements for GLENMARK PHARMACEUTICALS LTD. | Source: BSE India |